Aphria Inc. (APHA)
(Delayed Data from NYSE)
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Aphria Inc. (APHA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $7.12 in the latest trading session, marking a -1.25% move from the prior day.
ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant
by Sweta Killa
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Company News for Dec 17, 2020
by Zacks Equity Research
Companies In The News Are: GOOGL, LUV, TLRY, APHA, GLPG, GILD.
Aphria Inc. (APHA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $7.88, marking a -1.13% move from the previous day.
Top ETF of November & Its Best Stocks
by Sweta Killa
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of November with impressive returns of more than 47%.
Should You Buy Cannabis Stocks & ETFs Now?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the recent developments in the space.
Aphria Inc. (APHA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aphria Inc. (APHA) delivered earnings and revenue surprises of 66.67% and -8.31%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
Aphria (APHA) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Aphria's (APHA) fiscal first-quarter results are likely to reflect higher sales from medical and adult-use cannabis products.
Aphria Inc. (APHA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $5.75 in the latest trading session, marking a +1.41% move from the prior day.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $4.40 in the latest trading session, marking a -0.68% move from the prior day.
Aphria Inc. (APHA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $4.23 in the latest trading session, marking a +0.24% move from the prior day.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $4.64, marking a -0.22% move from the previous day.
Aphria Inc. (APHA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $4.51, moving +1.58% from the previous trading session.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $4.78 in the latest trading session, marking a -1.85% move from the prior day.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $4.57, moving -0.22% from the previous trading session.
Aphria Inc. (APHA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aphria Inc. (APHA) delivered earnings and revenue surprises of -233.33% and 3.94%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
Find Strong Stocks During Earnings Season with this First Profit Screener
by Benjamin Rains
We used our 'First Profit' stock screener to help find stocks that could be worth considering during second quarter earnings season...
Aphria (APHA) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Aphria's (APHA) fiscal fourth-quarter results are likely to reflect higher sales from medical and adult-use cannabis products.
Aphria (APHA) Looks Good: Stock Adds 8.8% in Session
by Zacks Equity Research
Aphria (APHA) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Aphria Inc. (APHA) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $4.29, making no change from the previous trading session.
Aphria Inc. (APHA) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $4.48 in the latest trading session, marking no change from the prior day.
Here's Why You Should Add HMS Holdings to Your Portfolio Now
by Zacks Equity Research
Investor confidence is high on HMS Holdings (HMSY) stock, thanks to solid prospects.
Abbott's (ABT) FreeStyle Libre Study Outcome Favorable
by Zacks Equity Research
The latest study outcome aligns with the American Diabetes Association's recommended A1c level of 7% for adults with diabetes.
Here's Why You Should Add AngioDynamics to Your Portfolio
by Zacks Equity Research
AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.
HMS Holdings' Solution to Help Consumers Amid Coronavirus
by Zacks Equity Research
HMS Holdings (HMSY) offers a unique COVID-19 health management and communications solution to support consumers during the pandemic.